Results 191 to 200 of about 3,164,975 (245)

Pathological Consequences in Anti-HCV Antibody-Positive Organ Donation to an Anti-HCV Antibody-Negative Recipient

Transplantation Proceedings
The need to expand the pool of available organs for transplantation has meant that the use of marginal organs is increasingly widespread. The advent of antiviral therapy for hepatitis C virus (HCV) has made it possible to consider the donation of organs from HCV-positive donors and even from viremic donors.In HCV-positive to HCV-negative antibody donor
Rossetto A., Adani G. L., Baccarani U., Tulissi P., Bresadola V.   +4 more
openaire   +2 more sources

Improving anti-HCV therapy.

Discovery medicine, 2007
Hepatitis C virus (HCV) infects about 2% of the world population or approximately 123 million people. The disease causes a significant level of morbidity and mortality among those afflicted. The combination of interferon and ribavirin is effective in many patients.
Stanislas, Pol, Vincent O, Mallet
openaire   +1 more source

Anti-HCV et hémoglobinopathies

Revue Française de Transfusion et d'Hémobiologie, 1990
B, Mattlinger, A M, Couroucé, R, Girot
openaire   +2 more sources

Prevalence of anti-HCV in two Tanzanian villages

1992
The presence of anti-HCV antibodies was investigated in sera from a total of 123 inhabitants of two Tanzanian villages. In one of the villages, 72.2% of the sera and in the other village, 82.6% of the sera were found to be anti-HCV positive. These values are dramatically higher than other reported prevalences, whereby cross-reactivity between HCV and ...
I, Ilardi, G, Errera, G M, De Sanctis, I G, Barbacini, A, Madera, F, Leone, A, Nderingo, A, Antognoli, L V, Chircu   +8 more
openaire   +2 more sources

Salivary anti-HCV as a marker of serum anti-HCV. A followup cohort study

Journal of Hepatology, 2001
E. Sikuler, S. Elsana, A. Yaari, Y. Shemer-Avni, L. Naggan, M. Margalith   +5 more
openaire   +2 more sources

ISG12a inhibits HCV replication and potentiates the anti-HCV activity of IFN-α through activation of the Jak/STAT signaling pathway independent of autophagy and apoptosis.

Virus Research, 2017
Yanzhao Chen, B. Jiao, Min Yao, Xuezhen Shi, Zhebin Zheng, Shilin Li, Limin Chen   +6 more
semanticscholar   +1 more source

Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios.

Journal of Hepatology, 2015
I. Wolffram, D. Petroff, O. Bätz, K. Jedrysiak, Jan Kramer, H. Tenckhoff, T. Berg, J. Wiegand   +7 more
semanticscholar   +1 more source

Long term stability of HBsAg, anti-HBc and anti-HCV in dried blood spot samples and eluates.

Journal of Clinical Virology, 2015
G. McAllister, S. Shepherd, K. Templeton, C. Aitken, R. Gunson   +4 more
semanticscholar   +1 more source

Prevalence of anti-HCV antibodies in Cameroon

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1991
Mencarini P, DE LUCA, ANDREA, Antinori A, Maiuro G, Spedini G, Bailly C, Tamburrini E.   +6 more
openaire   +3 more sources

Impact of anti HCV (+) on renal transplantation

Transplantation Proceedings, 2000
D J, Han, J H, Jung, H J, Jang, S K, Kim, S C, Kim   +4 more
openaire   +2 more sources